Related Experiment Video
Updated: May 15, 2025
09:58
RhoC GTPase Activation Assay
Published on: August 22, 2010
12.4K
A Systematic Analysis of Expression and Function of RAS GTPase-Activating Proteins (RASGAPs) in Urological Cancers: A
Hao Song1, Guojing Wang1, Guoqiang Gao1
1Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Cancers
|May 14, 2025
Summary
RAS GTPase-activating proteins (RASGAPs) regulate the RAS signaling pathway, crucial in urological cancers. Their dysregulation drives cancer progression and impacts treatment sensitivity, highlighting RASGAPs as potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- The RAS signaling pathway is frequently dysregulated in urological cancers.
- RAS GTPase-activating proteins (RASGAPs) are key negative regulators of RAS signaling, catalyzing the conversion of active RAS-GTP to inactive RAS-GDP.
- Loss or reduced function of RASGAPs can lead to aberrant RAS pathway activation, promoting cancer development and progression.
Purpose of the Study:
- To investigate the role of RASGAP dysregulation in the progression of urological cancers.
- To explore the potential of RASGAPs as therapeutic targets in prostate cancer, bladder cancer, and renal cell carcinoma.
- To understand how alterations in RASGAP expression affect treatment response.
Main Methods:
- Review of existing literature on RAS signaling and RASGAPs in urological malignancies.
- Analysis of genetic and expression data related to RASGAPs in cancer databases.
- Correlation analysis between RASGAP alterations and clinical outcomes, including treatment sensitivity.
Main Results:
- RASGAP dysregulation is a significant contributor to the progression of major urological cancers like prostate, bladder, and renal cell carcinoma.
- Altered RASGAP expression levels correlate with patient response to chemotherapy, radiotherapy, and targeted therapies.
- RASGAPs represent promising therapeutic targets for personalized treatment strategies in urological oncology.
Conclusions:
- RASGAPs play a critical role in controlling RAS signaling and are implicated in urological cancer pathogenesis.
- Targeting RASGAPs offers a potential avenue for developing novel and effective treatments for urological cancers.
- Further research into the RAS signaling network and personalized medicine approaches is essential for optimizing RASGAP-targeted therapies.
Related Concept Videos
02:38The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
01:24Small GTPases - Ras and Rho
3.8K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.8K
02:14GTPases and their Regulation
8.2K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
8.2K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:22Activation and Inactivation of G Proteins
6.5K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.5K